Skip to Content

AP National News

Probe: Alzheimer’s drug approval ‘rife with irregularities’

WASHINGTON (AP) — The Food and Drug Administration’s contentious approval of a questionable Alzheimer’s drug took another hit Thursday as congressional investigators called the process “rife with irregularities.” The 18-month investigation by two House committees detailed “atypical collaboration” between FDA regulators and a company it’s supposed to oversee — Aduhelm manufacturer Biogen. The probe also

Continue Reading

Report shines new light on execution secrecy in Tennessee

By KIMBERLEE KRUESI and JONATHAN MATTISE Associated Press NASHVILLE, Tenn. (AP) — When multiple pharmaceutical companies objected to Tennessee using their drugs to kill death row inmates several years back, the scramble to find lethal injection chemicals needed to carry out state-sanctioned executions grew frantic. “What are your thoughts on acquiring it through a veterinarian?”

Continue Reading